Chris Abell – författare
207 kr
Lyssna direkt efter köp
Freedom of speech is indispensable to a free and civilized society, yet this precious right is increasingly under attack today.
Islamic totalitarians repeatedly threaten and kill those deemed blasphemers while our political leaders stand idly by—and many intellectuals blame the victims. College students seek “trigger warnings” and “safe spaces” from controversial ideas. The government harasses tea party groups, preventing them from speaking out during an election, and it investigates oil companies and advocacy groups for the “crime” of dissenting from climate change orthodoxy.Why is this happening? What can be done?
This hard-hitting collection provides answers. Applying Ayn Rand’s philosophy of Objectivism to the most pressing free speech issues of the day, the essays in this book reveal the attacks on free speech to be the product of destructive ideas—ideas that are eroding Western culture at its foundation. They expose those ideas and the individuals who hold them, and, importantly, they identify the only ideas on which Western civilization can be sustained: reason, egoism, and individual rights.
2 754 kr
Läs direkt efter köp
Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique.
This book is written from a Chemist''s perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques.
2 754 kr
Läs direkt efter köp
Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique.
This book is written from a Chemist''s perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques.
2 501 kr
Tillfälligt slut